Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology

M. A. Weinstock and J. W. Horm
Department of Preventive Medicine and Clinical Epidemiology, Harvard Medical School, Boston, MA.

The etiology of mycosis fungoides is obscure, and the risk factors for its occurrence are poorly documented. This investigation uses data from nine US population-based cancer registries to investigate the descriptive epidemiology of this disorder. From 1973 through 1984, 721 newly diagnosed cases of mycosis fungoides were reported to these registries (0.29 cases per 100,000 population per year). A dramatic increase in the incidence of mycosis fungoides was noted over the period of this study. The incidence was highest among the elderly. Blacks were twice as likely to be afflicted as whites, and the incidence among men was more than twice the incidence among women. The geographic variation in incidence was associated with several demographic variables, including population density, family income, and concentration of physicians. Analysis of mortality among these patients revealed no evidence of detection bias.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mycosis Fungoides With Leptomeningeal Involvement
Wabulya et al.
JCO 2007;25:5658-5661.
FULL TEXT  

Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-2002
Criscione and Weinstock
Arch Dermatol 2007;143:854-859.
ABSTRACT | FULL TEXT  

Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and Sezary Syndrome: Evidence From Population-Based and Clinical Cohorts
Huang et al.
Arch Dermatol 2007;143:45-50.
ABSTRACT | FULL TEXT  

Presence of Circulating CCR10+ T cells and Elevated Serum CTACK/CCL27 in the Early Stage of Mycosis Fungoides.
Fujita et al.
Clin. Cancer Res. 2006;12:2670-2675.
ABSTRACT | FULL TEXT  

Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3, the Human UNC-53 Homologue
Karenko et al.
Cancer Res. 2005;65:8101-8110.
ABSTRACT | FULL TEXT  

The Pathogenesis of Mycosis Fungoides
Girardi et al.
NEJM 2004;350:1978-1988.
FULL TEXT  

Brainstem Involvement With Mycosis Fungoides: An Unusual Central Nervous System Complication
del Carpio-O'Donovan and Freeman
Am. J. Neuroradiol. 2002;23:533-534.
ABSTRACT | FULL TEXT  

Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma
Breneman et al.
Arch Dermatol 2002;138:325-332.
ABSTRACT | FULL TEXT  

Lymphoma of the Skin
Connors et al.
ASH Education Book 2002;2002:263-282.
ABSTRACT | FULL TEXT  

Fas Ligand Expression by Neoplastic T Lymphocytes Mediates Elimination of CD8+ Cytotoxic T Lymphocytes in Mycosis Fungoides: A Potential Mechanism of Tumor Immune Escape?
Ni et al.
Clin. Cancer Res. 2001;7:2682-2692.
ABSTRACT | FULL TEXT  

Drug Approval Summaries: Arsenic Trioxide, Tamoxifen Citrate, Anastrazole, Paclitaxel, Bexarotene
Cohen et al.
The Oncologist 2001;6:4-11.
ABSTRACT | FULL TEXT  

Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts
Siegel et al.
JCO 2000;18:2908-2925.
ABSTRACT | FULL TEXT  

Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts
Pandolfino et al.
JCO 2000;18:2152-2168.
ABSTRACT | FULL TEXT  

Mycosis Fungoides: Disease Evolution and Prognosis of 309 Dutch Patients
van Doorn et al.
Arch Dermatol 2000;136:504-510.
ABSTRACT | FULL TEXT  

Can Dermatopathologists Reliably Make the Diagnosis of Mycosis Fungoides?: If Not, Who Can?
Ming and LeBoit
Arch Dermatol 2000;136:543-546.
FULL TEXT  

EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
Willemze et al.
Blood 1997;90:354-371.
ABSTRACT | FULL TEXT  

Cutaneous T cell lymphomas
Bunn
BMJ 1994;308:551-552.
FULL TEXT